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Abstract 
In the present study the hepatoprotective efficacy of two edible macrofungi Dacryopinax 
spathularia and Schizophyllum commune has been assessed against CCl4-induced 
hepatotoxicity in albino wistar rats. The administration of CCl4(1ml/Kg) resulted into signif-
icant (p<0.05) rise in the levels of liver function marker enzymes Alanine Transaminase 
(ALT), Aspartate Aminotransferase (AST), Alkaline Phosphatase (ALP) and bilirubin and 
decrease in the levels of total protein and albumin in blood. On administration of low dose 
(250mg/Kg) and high dose (500mg/Kg) of both macrofungal extracts in different hepato-
toxic group of rats, the serum levels of AST, ALT, ALP and bilirubin significantly (p<0.05) 
lowered down and the levels of total protein and albumin significantly (p<0.05) increased 
in comparison to the hepatotoxic group of rats, reflecting the hepatoprotective impact of 
both the extracts.  
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INTRODUCTION 
Liver is a large, complex and vital organ of the 
body, involved in diversified functions like metabo-
lism of food molecules, detoxification of toxic 
agents, drugs or waste products of metabolism 
such as ammonia, recycling of breakdown prod-
ucts of RBCs and bile synthesis, synthesis of plas-
ma proteins including clotting factors, mainte-
nance of blood glucose level through glycogenesis 
and glycogenolysis and many other biochemical 
and physiological functions. Therefore any  hepa-
totoxic  factor may produce serious health conse-
quences by inducing liver damage, which is indi-
cated by abnormal levels of marker enzymes in 
blood like Alanine Transaminase (ALT), Aspartate 
Aminotransferase (AST), Alkaline Phosphatase 
(ALP), Serum Albumin, Total Protein and Bilirubin 
(Das and Sattegiri, 2018; Maity and Ahmad, 
2012). Liver damage is a widespread problem 
across the world and in most of the cases of liver 
damage oxidative stress is involved, which is char-
acterized by a progressive change from steatosis 
to chronic hepatitis, fibrosis, cirrhosis and some-
times hepatocellular carcinoma (Kodavanti et al., 
1989). Moreover, Oxidative stress has been in-
volved in the pathogenesis of a variety of patho-
physiological conditions of liver damage, such as 
exposure to hepatotoxins, alcoholic liver injury, 
viral hepatitis, intrahepatic cholestasis, billiary dis-
ease, liver ischemia and liver necrosis (Adeyemi, 
2014; Stephens, 2003). Carbon Tetrachloride 
(CCl4) is toxic to liver and kidney and is used fre-
quently in scientific research works to induce the 
hepatotoxicity in animal models and to evaluate 
the hepatoprotective potentiality of the hepatopro-
tective agents (Seifert et al., 1994)  
Macrofungi, also called as Mushrooms, belong to 
two major groups Ascomycota and Basidiomyco-
ta, which include approximately 10000 species 
and among  these about 3000 species are consid-
ered as edible, in which 700 species have been 
found to have pharmacological properties (Chang 
and Miles, 2004; Karaman et al., 2012; Wasser 
and Weis, 1999.). Mushrooms are not only prized 
for their value as a rich nutritional dietary source 
but also for their pharmacological efficacy 
(Lindequist et al., 2005). Edible macrofungi or 
mushrooms contain various potent bioactive 
chemical constituent compounds like tannins, sap-
onins, alkaloids, flavonoids, phenolics etc., which 
possess many pharmacological properties like 
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antioxidant (Peralta et al., 2008; Dandapat and 
Sinha, 2015 ), anti-inflammatory (Moro et al., 
2012), anti-diabetic (Hu. et al., 2006), antimicrobi-
al (Barros et al., 2007 ), immunomodulatory and 
anti-cancerous (Moradali et al., 2007). Moreover, 
hepatoprotective impact of macrofungi has been 
reported by many workers (Jayakumar et al., 
2006; Andreia et al., 2013).  
Dacryopinax spathularia (Schwein) and Schizo-
phyllum commune (Fries) are two edible macro-
fungi belonging to group Basidiomycota and are 
traditionally used as anti-diabetic, antibacterial, 
anti-inflammatory, hepatoprotective and nephro-
protective food supplement. Kumar et al (2018) 
have reported the mycochemical composition and 
antioxidant potentiality of these two edible macro-
fungi and found that both the macrofungi have 
significant antioxidant capacity. The present work 
was aimed to assess the hepatoprotective efficacy 
of D. spathularia and S. commune and to evaluate 
them as hepatoprotective neutraceutical agents 
using albino rats as animal model. 
MATERIALS AND METHODS 
Animals: Wistar albino rats (Rattus norvegicus) 
weighing about 175-200 g were used in the study. 
The rats were maintained under standard labora-
tory conditions at a temperature of 25±5ºC and 
relative humidity of 50±15%. The Dark-light cycle 
of 12 hrs. was maintained throughout the experi-
mental period of time. The animals were fed with 
commercial pellet diet and water ad libitum. The 
rats were kept in Polypropylene cages with paddy 
husk as bedding material. The experiment was 
carried out as per the approval of  Ethics commit-
tee of Ranchi University, Ranchi. 
Acute toxicity studies: The OECD guidelines 
(2004) have been followed for acute toxicity stud-
ies. Different doses of both macrofungal extracts 
were administered to two different groups of 10 
rats, where each group received one macrofungal 
extract. The extracts were fed orally by oral feed-
ing tube. No mortality was observed up to the dos-
es of 2000 mg/kg body weight (BW) /day within 48 
hrs. 
Induction of hepatotoxicity and Evaluation of 
hepatoprotective efficacy: Hepatotoxicity was 
induced by intra-peritoneal (i.p.) administration of 
1 ml/kg BW every 72 hrs. for 14 days of a mixture 
containing 30% CCl4 and liquid paraffin (1:2 V/V). 
Animals were equally divided into six groups 
(Group 1, 2, 3, 4, 5, 6) containing 10 animals each 
and the experiment was carried as follows: 
Group 1: Served as Control, received 1 ml of dis-
tilled water orally 
Group 2: Considered as hepatotoxic, received 
1ml/Kg i.p. of CCl4 every 72 hrs. 
Group 3: Hepatotoxic rats treated as above, re-
ceived 250 mg/Kg BW/day of D. spathularia    ex-
tract (LD); LD= Low Dose 
Group 4: Hepatotoxic rats treated as above,  
received 500 mg/Kg BW/day of D. spathularia 
extract (HD); HD= High Dose 
Group 5: Hepatotoxic rats treated as above,  
received 250 mg/Kg BW/ day of S. commune ex-
tract (LD) 
Group 6: Hepatotoxic rats treated as above,  
received 500 mg/Kg BW/day of S. commune ex-
tract (HD) 
Sample collection and assessment of  
biochemical parameters: The experiment was 
carried for 14 consecutive days. At the end of the 
experimental period all the animals were kept fast-
ing overnight and then blood was collected by 
retro-orbital bleeding under light ether anesthesia. 
Three blood samples were collected randomly 
from each group. The blood samples were placed 
in test tubes and allowed to clott for 30 minutes. 
Then the blood samples were centrifuged at 2500 
rpm for 10 minutes to get the clear serum and 
biochemical investigations were carried out. Total 
protein and Albumin were estimated following the 
method of Kingsley and Frankel (1939), serum 
ALT (U/L) and AST (U/L) were measured following 
the method of Reitman and Frankel (1957) and 
serum AST (U/L) was measured following the 
method of Bessey et al. (1964). 
Statistical analysis: Data was taken in triplicate 
and expressed as mean± standard error of mean. 
Statistical analysis was done by one way ANOVA 
followed by student’s t-test, statistical significance 
of values was considered at p<0.05. 
RESULTS 
The hepatoprotective effect of S. commune ex-
tract on hepatotoxicity-induced rats is shown in 
Table 1. The concentration of liver function marker 
enzymes AST, ALT, ALP and bilirubin significantly 
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Table 1. Hepatoprotective efficacy of Schizophyllum commune extract against CCl4-induced hepatotoxicity in 
rats (Data expressed as mean±SE, n=3). aStatistically significant when compared to control group(p<0.05); 
bStatistically significant when compared to hepatotoxic group(p<0.05). 
Animal Groups Total Pro-
tein (g/dL) 
Serum Al-
bumin(g/dL) 
Bilirubin 
(mg/dL) 
AST(U/L) ALT(U/L) ALP(U/L) 
Group 1(Control) 8.26±0.34 3.48±0.12 0.68±0.09 48.30±2.56 57.46±3.35 94.52±4.35 
Group2(CCl4treated/
Hepatotoxic) 
4.78±0.26a 2.02±0.52a 2.14±0.22a 124.20±9.68a 168.36±12.25a 134.91±7.15a 
Group5(Hepatotoxic+ LD 
of S. commune extract) 
7.92±0.46ab 3.34±0.16b 0.86±0.14a
b 
63.62±4.23ab 71.83±5.28ab 104.12±5.79ab 
Group 6(Hepatotoxic + HD 
of S. commune extract) 
8.51±0.56b 3.57±0.22b 0.72±0.14b 51.46±6.22b 63.16±5.18ab 102.08±6.63ab 
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(p=0.01) increased and the concentration of total 
protein and albumin significantly (p=0.01) de-
creased in toxicity-induced rats (group2), in com-
parison to the normal control group. On admin-
istration of low dose (250 mg/Kg BW) and high 
dose (500mg/Kg BW) of S. commune extract to 
the hepatotoxic rats, the concentration of AST, 
ALT, ALP and bilirubin significantly (p<0.05) de-
creased and concentration of total protein and 
serum albumin significantly (p<0.05) increased, in 
comparison to the hepatotoxic group of rats.  
The results of hepatoprotective effect of D. 
spathularia extract has been shown in Table 2. 
The administration of  LD and HD of D. spathular-
ia extract showed significant (p<0.05) decrease in 
the concentration of AST, ALT, ALP and bilirubin 
and significant (p<0.05) elevation in the concen-
tration of toatal protein and albumin in the blood, 
in comparison to the CCl4-treated hepatotoxic 
rats.  
DISCUSSION 
The CCl4 induces hepatotoxicity by transforming 
into free radicals like trichloromethyl radical (CCl3
.) 
and trichloromethylperoxy radical (CCl3OO
.), 
which induces enhanced lipid peroxidation, activa-
tion of cytochrome 450 and release of pro-
inflammatory mediators like TNF-α which results 
in necrosis and induces oxidative stress-mediated 
liver damage (Edwards et al., 1993; Huo et al., 
2011). The enhanced oxidative stress and thereby 
the increased lipid peroxidation can lead to dam-
age in hepatocellular membranes (De Groot et al., 
1988). The concentration of liver function marker 
enzymes like AST, ALT, ALP and Bilirubin in 
blood increases due to liver billiary obstruction 
and degradation of hepatic cell membranes (Huo 
et al, 2011) whereas, the concentration of albumin 
and protein in blood decreases as a result of dam-
age of intracellular structures like mitochondria, 
endoplasmic reticulum, DNA etc. (Uru et al., 
2013).  
Chatterjee et al., (2011) has reported that wild 
edible mushroom Calocybe indica contains bioac-
tive compounds like flavonoids, phenolics etc. and 
it’s extract shows hepatoprotective impact by sta-
bilization of hepatocyte membrane and healing of 
hepatic parenchyma through antioxidant defense 
mechanism. The two experimental macrofungi 
taken for the present study have significant antioxi-
dant activity due to the potent mycochemical con-
stituent compounds present in them like tannins, 
saponins, alkaloids, flavonoids, phenolics etc. 
(Kumar et al., 2018). In the present study the two 
experimental macrofungal extracts have been ad-
ministered to CCl4-induced hepatotoxic rats at two 
respective doses i.e. low dose and high dose to 
different hepatotoxic groups of rats. The results 
clearly showed that the administration of extracts 
of both macrofungi significantly (p<0.05) lowered 
the concentration of AST, ALT, ALP and bilirubin in 
blood whereas total protein and albumin levels in 
blood significantly (p<0.05) increased (Table 1 and 
2). The results of the present work showed that 
comparatively both the experimental macrofungal 
extracts have more or less equal hepatoprotective 
impact on the CCl4-induced hepatotoxic rats.    
It has been reported by many workers that the 
lowering of AST, ALT, ALP and bilirubin concentra-
tion and enhancement in concentration of total 
protein and albumin in blood back to their respec-
tive normal levels are the signs of repair of hepatic 
toxicity and regeneration of hepatocytes 
(Thawbrew et al., 1987; Hussain et al., 2017).  In 
the present study the enhancement in AST, ALT, 
ALP, bulirubin levels and decrease in total protein 
and albumin in blood following the administration 
of CCl4 shows the hepatic toxicity induced by the 
chemical. Further, the consequential lowering of 
AST, ALT, ALP and bilirubin levels and enhance-
ment in total protein and albumin levels in blood 
following the administration of both the macrofun-
gal extracts showed the hepatoprotective activity 
of both macrofungi studied in this animal model.  
Conclusion 
Based on the results of present study it can be 
concluded that the edible macrofungi Dacryopinax 
spathularia and Schizophyllum commune possess 
more or less equal hepatoprotective efficacy in the 
present animal model. Therefore these two macro-
fungi can be used as hepatoprotective neutraceuti-
cal dietary sources and in the development of new 
potent hepatoprotective agents. 
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Table 2. Hepatoprotective efficacy of Dacryopinax spathularia extract against CCl4-induced hepatotoxicity in 
rats (Data expressed as mean±SE, n=3). 
Animal groups Total Pro-
tein(g/dL) 
Serum Al-
bumin(g/dL) 
Bilirubin 
(mg/dL) 
AST(U/L) ALT(U/L) ALP(U/L) 
Group 1(Control) 8.26±0.34 3.48±0.12 0.68±0.09 48.30±2.56 57.46±3.35 94.52±4.35 
Group2(CCl4treated/
Hepatotoxic) 
4.78±0.26a 2.02±0.52a 2.14±0.22a 124.20±9.68a 168.36±12.2
5a 
134.91±7.15a 
Group3(Hepatotoxic+ LD 
of D. spathularia extract) 
7.86±0.21ab 2.97±0.34ab 0.89±0.16ab 61.70±2.68ab 74.32±3.36ab 102.51±4.36ab 
Group4(Hepatotoxic+ HD 
of D. spathularia extract) 
8.12±0.26b 3.35±0.23b 0.74±0.16b 52.38±3.27ab 63.76±4.68ab 92.45±3.02b 
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